Jaeho primarily worked with clinical genomic data to identify genomic alterations that may help characterize various brain tumors for diagnostic, prognostic, and treatment purposes. He also focused on the genetic biomarkers for Avastin response in glioblastoma patients. He obtained an MD and Masters in Public Health from Harvard School and is now a resident in Neurology at Johns Hopkins.